Clinical trials recruiting for Primary Sjogren's Syndrome Combined With Pulmonary Hypertension

Fewer than 3 recruiting trials found.

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
  NCT06947460 · Phase: Phase 1, Phase 2 · Ages: 10 Years to 65 Years · Sex: All (male and female) · 1 location
• Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
  NCT06947473 · Phase: Phase 1, Phase 2 · Ages: 6 Years to 65 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Primary Sjogren's Syndrome Combined With Pulmonary Hypertension often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Primary Sjogren's Syndrome Combined With Pulmonary Hypertension trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.